These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11578586)

  • 1. [Clinical-biological characteristics of infiltrating ductal carcinomas of the breast with estrogen receptor concentrations >300 fmol/mg protein].
    Resino C; Arias JI; Del Río MC; Sánchez Hermosa C; Ruibal A
    Rev Esp Med Nucl; 2001 Oct; 20(6):503-5. PubMed ID: 11578586
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast].
    Sánchez Salmón A; Argibay S; Arias JI; Ruibal A
    Rev Esp Med Nucl; 2005; 24(3):185-90. PubMed ID: 15847785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormone-dependent, diploid, infiltrating ductal breast carcinomas less than 2 cm in size: influence of an exclusive and moderate cellular proliferation on the clinicobiological features and recurrences of these malignant tumors].
    Ruibal A; Arias JI
    Rev Esp Med Nucl; 2002; 21(6):437-8. PubMed ID: 12425893
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the cytosolic concentrations of the tissue poly-peptide specific (TPS) antigen in infiltrating ductal carcinomas of the breast. Positive relationship with hormone dependency and negative with cellular proliferation].
    Ruibal A; Arias JI; Resino C; Lapeña G; Schneider J; Tejerina A
    Rev Esp Med Nucl; 2001 Aug; 20(5):365-8. PubMed ID: 11470070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infiltrating ductal carcinomas of the breast in women over 60 years of age. Association with higher cellular proliferation and lower PS2, cell surface and cytosolic hyaluronic acid concentrations].
    Ruibal A; Arias J; Del Río MC; Resino C; Tejerina A
    Rev Esp Med Nucl; 2001 Dec; 20(7):525-9. PubMed ID: 11709137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytosolic concentrations of cathepsin D in 88 infiltrating ductal breast carcinomas having negative estrogen and progesterone receptors. Correlation with other clinical and biological parameters].
    Ruibal A; Arias J; Lapeña G; García Díez S; Tejerina A
    Rev Esp Med Nucl; 2001 Jun; 20(4):332-3. PubMed ID: 11940423
    [No Abstract]   [Full Text] [Related]  

  • 8. MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter?
    Chen JH; Nalcioglu O; Su MY
    Ann Oncol; 2008 May; 19(5):1024-6. PubMed ID: 18375524
    [No Abstract]   [Full Text] [Related]  

  • 9. [Expression of epidermal growth factor receptor (EGFR) in hormone-independent breast cancers].
    Ruibal A; Garrido-Pumar M; Arias JI
    Rev Esp Med Nucl; 2006; 25(1):15-9. PubMed ID: 16540006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma.
    Adamkov M; Kajo K; Vybohova D; Krajcovic J; Stuller F; Rajcani J
    Neoplasma; 2012; 59(1):30-7. PubMed ID: 22103896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pS2 negativity in postmenopausal women with ER+PgR+ infiltrating ductal breast carcinoma is associated with reduced hormone dependence and increased proliferation and aneuploidy of the tumors.
    Ruibal A; Schneider J; del Rio C; Arias J; Núñez MJ; Piqueras V; Tejerina A
    Int J Biol Markers; 1999; 14(3):186-8. PubMed ID: 10569142
    [No Abstract]   [Full Text] [Related]  

  • 12. Pigmented Cutaneous Metastasis of Breast Carcinoma Mimicking a Melanoma.
    Ubillos N; Vola M; Mazzei ME; Magliano J
    Actas Dermosifiliogr; 2016 Oct; 107(8):699-701. PubMed ID: 27206606
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytosolic tissue-type plasminogen activator (t-PA) levels in ductal infiltrating carcinomas of the breast classified according to different clinical and biological parameters.
    García Muñiz JL; Alvarez A; Fernández Llana B; Fernández Raigoso P; Allende MT; Ruibal A
    Int J Biol Markers; 1995; 10(2):119-21. PubMed ID: 7561238
    [No Abstract]   [Full Text] [Related]  

  • 14. [Valoration of the epidermal growth factor receptor (EGFR) in benign breast disease and its relation with expression in malignant tumors classified by hormonal dependence].
    Allende MT; Raigoso PF; Alvarez A; Llana B; Sánchez A; Martínez MI; Miralles MT; Roiz C
    Rev Esp Med Nucl; 1999; 18(1):32-6. PubMed ID: 10074215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER2 as a prognostic factor in breast cancer.
    Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
    Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Zosteriform eruption resistant to acyclovir].
    Orgaz-Molina J; Cotugno M; Aneiros-Fernández J; Arias-Santiago S
    Med Clin (Barc); 2013 Aug; 141(4):188. PubMed ID: 23597955
    [No Abstract]   [Full Text] [Related]  

  • 17. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.
    Arpino G; Bardou VJ; Clark GM; Elledge RM
    Breast Cancer Res; 2004; 6(3):R149-56. PubMed ID: 15084238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the cytosolic content of the pS2 protein in breast cancer].
    Tamargo F; Vizoso F; Lamelas ML; Rodil A; Vérez P; Raigoso P; Mulero M; Vázquez J; Roiz C; Allende MT
    Rev Esp Med Nucl; 2002 Feb; 21(1):28-33. PubMed ID: 11820999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinico-biological impact of pS2 positivity in estrogen receptor negative-infiltrating ductal carcinomas of the breast].
    Ruibal A; Arias J; del Río MC; San Román JM; Lapeña G; Pardo C; Tejerina A
    Rev Esp Med Nucl; 2000 Oct; 19(6):428-33. PubMed ID: 11060273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cytosolic hyaluronic acid level defines several clinico-biological properties of CD44v5-positive infiltrating ductal carcinoma of the breast].
    Ruibal A; Arias JI; Carmen del Río M; San Román JM; Lapeña G; Schneider J; Tejerina A
    Med Clin (Barc); 2000 Jul; 115(6):201-7. PubMed ID: 11002457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.